European Journal of Pharmacology 1992: Vol 213 Index

16 Pages·1992·5.2 MB·English

European Journal of Pharmacology, 213 (1992) 471-474
© 1992 Elsevier Science Publishers B.V. All rights reserved 0014-/2929 /9$059.0 0
Author index
Abadie, P., Baron, J.C., Bisserbe, J.C., Boulenger, J.P., Rioux, P., Bungardt, E., Vockert, E., Feifel, R., Moser, U., Tacke, R.,
Travere, J.M., Barré, L., Petit-Taboué, M.C. and Zarifian, E. Mutschler, E., Lambrecht, G. and Surprenant, A.
Central benzodiazepine receptors in human brain: estimation of Characterization of muscarinic receptors mediating vasodilation
regional B and Kj values with positron emission tomography in guinea-pig ileum submucosal arterioles by the use of com-
max
(213) 107 puter-assisted videomicroscopy (213) 53
Abiko, Y., see Nasa, Y. (213) 171
Ahrén, B., see Karlsson, S. (213) 145 Castro-Faria-Neto, H.C., Bozza, P.T., Silva, A.R., Silva, P.M.R.,
Aihara, K., see Matsumoto, Y. (213) 167 Lima, M.C.R., Martins, M.A., Cordeiro, R.S.B. and Vargaftig,
Amerini, S., see Mantelli, L. (213) 79 B.B.
Arnt, J., Hyttel, J. and Sanchez, C. Interference of azelastine with anaphylaxis induced by ovalbumin
Partial and full dopamine D, receptor agonists in mice and rats: challenge in actively sensitized rats (213) 183
relation between behavioural effects and stimulation of adenylate Castro, M., see Mota-Filipe, H. (213) 227
cyclase activity in vitro (213) 259 Cayla, J., see Varastet, M. (213) 275
Ceci, A., see Volonté, M. (213) 163
Chaouloff, F., see Baudrie, V. (213) 41
Babycos, C.R., see Nossaman, B.D. (213) 1
Chauhan, N.S., see Beer, M.S. (213) 193
Bagetta, G., lannone, M., Scorsa, A.M. and Nisticd, G.
Chavoix, C., see Varastet, M. (213) 275
Tacrine-induced seizures and brain damage in LiCl-treated rats Christakos, S., see Walters, M.R. (213) 309
can be prevented by N“-nitro-L-arginine methyl ester (213) 301
Chung, K.F., see Sakamoto, T. (213) 367
Barnes, P.J., see Sakamoto, T. (213) 367
Clark, D., see Overton, P. (213) 165
Baron, J.C., see Abadie, P. (213) 107
Cometta-Morini, C., see Maguire, P. (213) 219
Barré, L., see Abadie, P. (213) 107
Cordeiro, R.S.B., see Castro-Faria-Neto, H.C. (213) 183
Baudrie, V. and Chaouloff, F.
Corley, K.C., Singh, V.B., Phan, T.-H. and Boadle-Biber, M.C.
Mechanisms involved in the hyperglycemic effect of the 5- Effect of gepirone on increases in tryptophan hydroxylase in
HT,,-/5-HT, receptor agonist, DOI (213) 41
response to sound stress (213) 417
Beer, M.S., Stanton, J.A., Bevan, Y., Chauhan, N.S. and Middlemiss, Couture, R., see Décarie, A. (213) 125
D.N. Crouzel, C., see Varastet, M. (213) 275
An investigation of the 5-HT,, receptor binding affinity of 5-hy-
droxytryptamine, 5-carboxyamidotryptamine and sumatriptan in Daly, S.A. and Waddington, J.L.
the central nervous system of seven species (213) 193 Two directions of dopamine D,/D, receptor interaction in stud-
Bennett, T., see Gardiner, $.M. (213) 449 ies of behavioural regulation: a finding generic to four new,
Berridge, T.L., Doxey, J.C. and Roach, A.G. selective dopamine D, receptor antagonists (213) 251
Comparison of the effects of efaroxan and glibenclamide on Damase-Michel, C., see Montastruc, P. (213) 159
plasma glucose and insulin levels in rats (213) 213 Décarie, A. and Couture, R.
Berridge, T.L., Doxey, J.C., Roach, A.G. and Smith, C.F.C. Characterization of the peripheral action of neuropeptide K on
Selectivity profile of the a@,-adrenoceptor antagonist efaroxan in the rat cardiovascular system (213) 125
relation to plasma glucose and insulin levels in the rat (213) 205 Dhasmana, K.M., Villalon, C.M., Zhu, Y.N., Tadipatri, $. and Sax-
Bertolini, A., see Poggioli, R. (213) 87 ena, P.R.
Bevan, Y., see Beer, M.S. (213) 193 Role of 5-HT,-like receptors in the increase in intragastric pres-
Bischoff, C. and Tiedtke, P.I. sure induced by 5-hydroxytryptamine in the rat (213) 293
Competitive and non-competitive NMDA receptor antagonists in Dijcks, F.A., see Fernhout, B.J.H. (213) 313
spatial learning tasks (213) 269 Doxey, J.C., see Berridge, T.L. (213) 205
Bisserbe, J.C., see Abadie, P. (213) 107 Doxey, J.C., see Berridge, T.L. (213) 213
Boadle-Biber, M.C., see Corley, K.C. (213) 417 Drukarch, B., see Stoof, J.C. (213) 439
Bonanno, G., see Raiteri, M. (213) 17
Booij, J., see Stoof, J.C. (213) 439 Elliott, P.J., see Overton, P. (213) 165
Borsini, F., see Volonté, M. (213) 163 Eltze, M., see Bott, A. (213) 141
Bott, A., Eltze, M. and Illes, P. Elwood, W., see Sakamoto, T. (213) 367
External ATP antagonizes the effect of potassium channel open- Emeis, J.J., see Tranquille, N. (213) 285
ers in guinea-pig ventricular papillary muscle (213) 141 Endo, Y., see Hattori, Y. (213) 147
Bottlaender, M., see Varastet, M. (213) 275
Bo: lenger, J.P., see Abadie, P. (213) 107 Fedele, E., see Raiteri, M. (213) 17
Bousquet, P., see Suaud-Chagny, M.F. (213) 305 Feifel, R., see Bungardt, E. (213) 53
Bozza, P.T., see Castro-Faria-Neto, H.C. (213) 183 Fernhout, B.J.H., Dijcks, F.A., Moolenaar, W.H. and Ruigt, G.S.F.
Brouillet, E., see Varastet, M. (213) 275 Lysophosphatidic acid induces inward currents in Xenopus laevis
Brune, K., see Zeilhofer, H.U. (213) 155 oocytes; evidence for an extracellular site of action (213) 313
472
Fetzer, C., see Walters, M.R. (213) 309 Karlsson, S. and Ahrén, B.
Fiekers, J.F., see Heppner, T.J. (213) 427 CCK-8-stimulated insulin secretion in vivo is mediated by CCK,
Fischette, C.T., see Walters, M.R. (213) 309 receptors (213) 145
Fredow, G., see LOscher, W. (213) 31 Kasuya, Y., see Kamei, J. (213) 137
Fiuckel, D. and Petzinger, E. Kato, H., see Morikawa, K. (213) 409
Interaction of sulfonylureas with the transport of bile acids into Katz, J.L., see Schindler, C.W. (213) 99
hepatocytes (213) 393 Kemp, P.A., see Gardiner, S.M. (213) 449
Fiickel, D., see Petzinger, E. (213) 381 Kigoshi, S., see Hashimoto, S. (213) 117
Fujimoto, J.M., see Suh, H.H. (213) 337 Korpi, E.R., Uusi-Oukari, M. and Wegelius, K.
Substrate specificity of diazepam-insensitive cerebellar [*H]Ro
15-4513 binding sites (213) 323
Gardiner, S.M., Kemp, P.A., Bennett, T., Palmer, R.M.J. and Mon-
cada, S.
Nitric oxide synthase inhibitors cause sustained, but reversible, Lambrecht, G., see Bungardt, E. (213) 53
hypertension and hindquarters vasoconstriction in Brattleboro Ledda, F., see Mantelli, L. (213) 79
rats (213) 449 Lima, M.C.R., see Castro-Faria-Neto, H.C. (213) 183
Geisslinger, G., see Zeilhofer, H.U. (213) 155 Loew, G., see Maguire, P. (213) 219
Giao-T.-Rico, J.M., see Mota-Filipe, H. (213) 227 Loscher, W. and Fredow, G.
Giridhar, J., Peoples, R.W. and Isom, G.E. Effects of pharmacological manipulation of dopaminergic and
Modulation of hypothalamic norepinephrine release by atrial cholinergic neurotransmission in genetically dystonic hamsters
natriuretic peptide: involvement of cyclic GMP (213) 317 (213) 31
Goldberg, S.R., see Schindler, C.W. (213) 99 Loscher, W., see Rundfeldt, C. (213) 351
Gomi, Y., see Morikawa, K. (213) 409
Gonon, F., see Suaud-Chagny, M.F. (213) 305 Maguire, P., Tsai, N., Kamal, J., Cometta-Morini, C., Upton, C. and
Loew, G.
Pharmacological profiles of fentanyl analogs at uw, 6 and « opiate
Hagan, R.M., see Overton, P. (213) 165
Hakanson, R., see Wang, Z.-Y. (213) 235 receptors (213) 219
Majewski, H., see Mian, M.A. (213) 47
Harms, L., see Tschépl, M. (213) 71
Mantelli, L., Amerini, S., Rubino, A. and Ledda, F.
Hashimoto, S., Kigoshi, S. and Muramatsu, I.
Effects of thromboxane agonists on cardiac adrenergic neuro-
Neurogenic responses of urethra isolated from the dog (213) 117
transmission (213) 79
Hashimoto, S., see Morikawa, K. (213) 409
Marchi, M., see Raiteri, M. (213) 17
Hattori, Y., Nagashima, M., Endo, Y. and Kanno, M.
Martins, M.A., see Castro-Faria-Neto, H.C. (213) 183
Glibenclamide does not block arterial relaxation caused by va-
Matsumoto, Y., Ochi, H., Aihara, K., Inui, J. and Ikegami, K.
soactive intestinal polypeptide (213) 147
Effects of Y-20811, a thromboxane A, synthetase inhibitor, on
Heppner, T.J. and Fiekers, J.F.
experimentally induced coronary thrombosis in anesthetized dogs
Compound 48 /80 blocks transmission and increases the excitabil-
(213) 167
ity of ganglion neurons (213) 427
May, B., see Walters, M.R. (213) 309
Hood, J.S., see Nossaman, B.D. (213) 1
Maziére, B., see Varastet, M. (213) 275
Hoque, A.N.E., see Nasa, Y. (213) 171
Maziére, M., see Varastet, M. (213) 275
Horii, A., see Okakura, K. (213) 189
McMahon, T.J., see Nossaman, B.D. (213) 1
Hyttel, J., see Arnt, J. (213) 259
Meldrum, B.S., see Smith, S.E. (213) 133
Mermet, C., see Suaud-Chagny, M.F. (213) 305
Iannone, M., see Bagetta, G. (213) 301
Mian, M.A., Majewski, H. and Rand, M.J.
Ibrahim, I.N., see Nossaman, B.D. (213) 1
An inhibitory effect of isoprenaline on stimulation-induced nor-
Ichihara, K., Nabeshima, T. and Kameyama, T.
adrenaline release from rat atria (213) 47
Effects of dopamine receptor agonists on passive avoidance learn-
Middlemiss, D.N., see Beer, M.S. (213) 193
ing in mice: interaction of dopamine D, and D, receptors (213)
Misawa, M., see Suzuki, T. (213) 91
243
Miyamori, I., see Takeda, Y. (213) 445
Ichihara, K., see Nasa, Y. (213) 171
Mochizuki, T., see Okakura, K. (213) 189
Ikegami, K., see Matsumoto, Y. (213) 167
Moncada, S., see Gardiner, S.M. (213) 449
Illes, P., see Bott, A. (213) 141
Montastruc, J.-L., see Montastruc, P. (213) 159
Illes, P., see Tsch6pl, M. (213) 71
Montastruc, P., Damase-Michel, C., Tavernier, G., Tran, M.-A. and
Inostroza, H., see Pérez, H. (213) 435
Montastruc, J.-L.
Inui, J., see Matsumoto, Y. (213) 167
Release of neuropeptide Y and noradrenaline during afferent
Isom, G.E., see Giridhar, J. (213) 317
nerve stimulation (213) 159
Ito, Y., see Morikawa, K. (213) 409
Moolenaar, W.H., see Fernhout, B.J.H. (213) 313
Morikawa, K., Hashimoto, S., Yamauchi, T., Kato, H., Ito, Y. and
Jancar, S., see Tavares de Lima, W. (213) 63
Gomi, Y.
Inhibitory effect of inaperisone hydrochloride (inaperisone), a
Kadowitz, P.J., see Nossaman, B.D. (213) 1 new centrally acting muscle relaxant, on the micturition reflex
Kamal, J., see Maguire, P. (213) 219 (213) 409
Kamei, J. and Kasuya, Y. Moser, U., see Bungardt, E. (213) 53
The effect of hydrochlorothiazide on the enhanced coughing Mota-Filipe, H., Castro, M. and Giao-T.-Rico, J.M.
associated with treatment with enalapril (213) 137 Effect of DL-propranolol on nitric oxide production in perfused
Kameyama, T., see Ichihara, K. (213) 243 rat hindquarters (213) 227
Kameyama, T., see Toyoshi, T. (213) 25 Muramatsu, I., see Hashimoto, S. (213) 117
Kanno, M., see Hattori, Y. (213) 147 Mutschler, E., see Bungardt, E. (213) 53
Nabeshima, T., see Ichihara, K. (213) 243 Schindler, C.W., Tella, S.R., Katz, J.L. and Goldberg, S.R.
Nagase, H., see Suzuki, T. (213) 91 Effects of cocaine and its quaternary derivative cocaine methio-
Nagashima, M., see Hattori, Y. (213) 147 dide on cardiovascular function in squirrel monkeys (213) 99
Narita, M., see Suzuki, T. (213) 91 Schwarcz, R., see Wu, H.-Q. (213) 375
Nasa, Y., Hoque, A.N.E., Ichihara, K. and Abiko, Y. Scorsa, A.M., see Bagetta, G. (213) 301
Cardioprotective effect of pindolol in ischemic-reperfused iso- Selig, W. and Tocker, J.
lated rat hearts (213) 171 Effect of interleukin-| receptor antagonist on antigen-induced
Nistico, G., see Bagetta, G. (213) 301 pulmonary responses in guinea pigs (213) 331
Norenberg, W., see Tschdpl, M. (213) 71 Silva, A.R., see Castro-Faria-Neto, H.C. (213) 183
Nossaman, B.D., McMahon, T.J., Ragheb, M.S., Ibrahim, I.N., Baby- Silva, P.M.R., see Castro-Faria-Neto, H.C. (213) 183
cos, C.R., Hood, J.S. and Kadowitz, P_J. Singh, V.B., see Corley, K.C. (213) 417
Blockade of thromboxane /endoperoxide receptor-mediated re- Sirois, P., see Tavares de Lima, W. (213) 63
sponses in the pulmonary vascular bed of the cat by sulotroban Smith, C.F.C., see Berridge, T.L. (213) 205
(213) 1 Smith, S.E. and Meldrum, B.S.
The protein kinase C activators, phorbol 1|2-myristate,13-acetate
and phorbol 12,13-dibutyrate, are convulsant in the pico-
Ochi, H., see Matsumoto, Y. (213) 167
nanomolar range in mice (213) 133
Okakura, K., Yamatodani, A., Mochizuki, T., Horii, A. and Wada,
Snead, III, O.C.
H.
Evidence for GABA,-mediated mechanisms in experimental
Glutamatergic regulation of histamine release from rat hypotha-
generalized absence seizures (213) 343
lamus (213) 189
Stamidis, H. and Young, G.A.
Overton, P., Elliott, P.J., Hagan, R.M. and Clark, D.
Naltrindole retards tolerance development to morphine-induced
Neurokinin agonists differentially affect A9 and AlO dopamine
effects on EEG and EEG power spectra (213) 9
cells in the rat (213) 165
Stanton, J.A., see Beer, M.S. (213) 193
Stoof, J.C., Booij, J., Drukarch, B. and Wolters, E.C.
Palmer, R.M.J., see Gardiner, S$.M. (213) 449
The anti-parkinsonian drug amantadine inhibits the N-methyl-
Peoples, R.W., see Giridhar, J. (213) 317
D-aspartic acid-evoked release of acetylcholine from rat neostria-
Pérez, H., Ruiz, S., Inostroza, H. and Perretta, M.
tum in a non-competitive way (213) 439
Substance P depresses bioelectrical responses evoked in the nu-
Stulzaft, O., see Varastet, M. (213) 275
cleus tractus solitarii: interaction with y-aminobutyric acid-ergic
Suaud-Chagny, M.F., Mermet, C., Tibirica, E., Bousquet, P. and
neurons (213) 435
Gonon, F.
Perretta, M., see Pérez, H. (213) 435
Does rilmenidine act in vivo on central @,-adrenoceptors modu-
Petit-Taboué, M.C., see Abadie, P. (213) 107
lating noradrenaline release? (213) 305
Petzinger, E. and Fickel, D.
Sugden, D.
Evidence for a saturable, energy-dependent and carrier-mediated
Effect of putative melatonin receptor antagonists on melatonin-
uptake of oral antidiabetics into rat hepatocytes (213) 381
induced pigment aggregation in isolated Xenopus laevis
Petzinger, E., see Fiickel, D. (213) 393
melanophores (213) 405
Phan, T.-H., see Corley, K.C. (213) 417
Suh, H.H., Fujimoto, J.M. and Tseng, L.F.
Poggioli, R., Rasori, E. and Bertolini, A.
Different radiant heat intensities differentiate intracerebroven-
Galanin inhibits sexual behavior in male rats (213) 87
tricular morphine- from B-endorphin-induced inhibition of the
Prenant, C., see Varastet, M. (213) 275
tail-flick response in the mouse (213) 337
Surprenant, A., see Bungardt, E. (213) 53
Ragheb, M.S., see Nossaman, B.D. (213) | Suzuki, T., Narita, M., Takahashi, Y., Misawa, M. and Nagase, H.
Raiteri, M., Marchi, M., Bonanno, G., Fedele, E. and Versace, P. Effects of nor-binaltorphimine on the development of analgesic
Dopamine release and dopaminergic inhibition of acetylcholine tolerance to and physical dependence on morphine (213) 91
release in rat striatal slices after nigro-striatal hemitransection Swandulla, D., see Zeilhofer, H.U. (213) 155
and parenteral ganglioside administration (213) 17
Rand, M.J., see Mian, M.A. (213) 47
Tacke, R., see Bungardt, E. (213) 53
Rasori, E., see Poggioli, R. (213) 87
Tadipatri, S., see Dhasmana, K.M. (213) 293
Riggle, P.C., see Walters, M.R. (213) 309
Taira, N., see Yoneyama, F. (213) 199
Rioux, P., see Abadie, P. (213) 107
Takahashi, Y., see Suzuki, T. (213) 91
Roach, A.G., see Berridge, T.L. (213) 205
Takeda, R., see Takeda, Y. (213) 445
Roach, A.G., see Berridge, T.L. (213) 213
Takeda, Y., Miyamori, I., Yoneda, T. and Takeda, R.
Rubino, A., see Mantelli, L. (213) 79
Endothelin-1 release from the mesenteric arteries of cy-
Ruigt, G.S.F., see Fernhout, B.J.H. (213) 313
closporine-treated rats (213) 445
Ruiz, S., see Pérez, H. (213) 435
Tavares de Lima, W., Sirois, P. and Jancar, S.
Rundfeldt, C. and Loscher, W.
Immune-complex alveolitis in the rat: evidence for platelet acti-
Development of tolerance to the anticonvulsant effect of vigaba-
vating factor and leukotrienes as mediators of the vascular lesions
trin in amygdala-kindled rats (213) 351
(213) 63
Tavernier, G., see Montastruc, P. (213) 159
Sakamoto, T., Elwood, W., Barnes, P.J. and Chung, K.F. Taylor, C.P. and Vartanian, M.G.
Effect of Hoe 140, a new bradykinin receptor antagonist, on Probenecid pretreatment enhances anticonvulsant action of
bradykinin- and platelet-activating factor-induced bronchocon- NBQX in mice (213) 151
striction and airway microvascular leakage in guinea pig (213) 367 Tella, S.R., see Schindler, C.W. (213) 99
Sanchez, C., see Arnt, J. (213) 259 Tibaldo-Bongiorno, M., see Walters, M.R. (213) 309
Satoh, K., see Yoneyama, F. (213) 199 Tibiriga, E., see Suaud-Chagny, M.F. (213) 305
Saxena, P.R., see Dhasmana, K.M. (213) 293 Tiedtke, P.I., see Bischoff, C. (213) 269
474
Tocker, J., see Selig, W. (213) 331 Volonté, M., Ceci, A. and Borsini, F.
Toyoshi, T., Ukai, M. and Kameyama, T. Effect of haloperidol and clozapine on (+)SKF_ 10,047-induced
Combination of a 6 opioid receptor agonist but not a uw opioid dopamine release: role of 5-HT, receptors (213) 163
receptor agonist with the D,-selective dopamine receptor agonist
SKF 38393 markedly potentiates different behaviors in mice (213) Wada, H., see Okakura, K. (213) 189
25 Waddington, J.L., see Daly, S.A. (213) 251
Tran, M.-A., see Montastruc, P. (213) 159 Walters, M.R., Fischette, C.T., Fetzer, C., May, B., Riggle, P.C.,
Tranquille, N. and Emeis, J.J. Tibaldo-Bongiorno, M. and Christakos, S.
The involvement of products of the phospholipase pathway in the Specific 1,25-dihydroxyvitamin D, binding sites in choroid plexus
acute release of tissue-type plasminogen activator from perfused (213) 309
rat hindlegs (213) 285 Wang, Z.-Y. and Hakanson, R.
Travere, J.M., see Abadie, P. (213) 107 Effect of resiniferatoxin on the isolated rabbit iris sphincter
Tsai, N., see Maguire, P. (213) 219 muscle: comparison with capsaicin and bradykinin (213) 235
Tschopl, M., Harms, L., Norenberg, W. and Illes, P. Wegelius, K., see Korpi, E.R. (213) 323
Excitatory effects of adenosine 5’-triphosphate on rat locus Wolters, E.C., see Stoof, J.C. (213) 439
coeruleus neurones (213) 71 Wu, H.-Q., Ungerstedt, U. and Schwarcz, R.
Tseng, L.F., see Suh, H.H. (213) 337 Regulation of kynurenic acid synthesis studied by microdialysis in
the dorsal hippocampus of unanesthetized rats (213) 375
Ukai, M., see Toyoshi, T. (213) 25
Ungerstedt, U., see Wu, H.-Q. (213) 375 Yamada, H., see Yoneyama, F. (213) 199
Upton, C., see Maguire, P. (213) 219 Yamatodani, A., see Okakura, K. (213) 189
Uusi-Oukari, M., see Korpi, E.R. (213) 323 Yamauchi, T., see Morikawa, K. (213) 409
Yoneda, T., see Takeda, Y. (213) 445
Varastet, M.. Brouillet, E., Chavoix, C., Prenant, C., Crouzel, C.., Yoneyama, F., Yamada, H., Satoh, K. and Taira, N.
Stulzaft, O., Bottlaender, M., Cayla, J., Maziére, B. and Maziére, Vasodepressor mechanisms of 2-(1-octynyl)-adenosine (YT-146),
M. a selective adenosine A, receptor agonist, involve the opening of
In vivo visualization of central muscarinic receptors using glibenclamide-sensitive K* channels (213) 199
[''C]quinuclidinyl benzilate and positron emission tomography in Young, G.A., see Stamidis, H. (213) 9
baboons (213) 275
Vargaftig, B.B., see Castro-Faria-Neto, H.C. (213) 183 Zarifian, E., see Abadie, P. (213) 107
Vartanian, M.G., see Taylor, C.P. (213) 151 Zeilhofer, H.U., Swandulla, D., Geisslinger, G. and Brune, K.
Versace, P., see Raiteri, M. (213) 17 Differential effects of ketamine enantiomers on NMDA receptor
Villalon, C.M., see Dhasmana, K.M. (213) 293 currents in cultured neurons (213) 155
Vockert, E., see Bungardt, E. (213) 53 Zhu, Y.N., see Dhasmana, K.M. (213) 293
European Journal of Pharmacology, 213 (1992) 475-485
© 1992 Elsevier Science Publishers B.V. All rights reserved 0014-/2929 /9$059.0 0
Key word index
A-69024 Airway leukoctyes
Dopamine D, receptors; Dopamine D, receptors; Dopamine D, /D, Interleukin-1 receptor antagonists; Airway hyperreactivity; Substance
receptor interactions; Behaviour; Jerking; SCH 39166; NO 756; BW P; Bronchoalveolar lavage (Selig, W. (213) 331)
737C (Daly, S.A. (213) 251)
Airway microvascular leakage
Absence seizures Bradykinin; Bradykinin receptors; Bronchoconstriction; Hoe 140;
Epilepsy; GABA, receptors; GABA, receptors; y-Hydroxybutyric PAF (platelet-activating factor, PAF-acether) (Sakamoto, T. (213)
acid; Pentylenetetrazole (Snead, III, O.C. (213) 343) 367)
Acetylcholine Alcohol sensitivity
Dystonia; Dopamine; Anticholinergic drugs; Haloperidol; Levodopa; Ro 15-4513; Cerebellar diazepam-insensitive binding; Substrate
Apomorphine (Loscher, W. (213) 31) specificity; (Selected rat lines) (Korpi, E.R. (213) 323)
Amantadine
Acetylcholine release
NMDA receptors; Acetylcholine release; Neostriatum; Dopamine
Nigrostriatal hemitransection; Dopamine uptake; Dopamine release;
release (Stoof, J.C. (213) 439)
Ganglioside administration; (Recovery of function) (Raiteri, M. (213)
17)
Aminooxyacetic acid
Excitotoxicity; Kynurenic acid; Kynurenine; Microdialysis; Neuropro-
NMDA receptors; Amantadine; Neostriatum; Dopamine release
tection (Wu, H.-Q. (213) 375)
(Stoof, J.C. (213) 439)
AMPA (2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionate
Action potentials
Quinoxalinedione; Epilepsy; Seizure; Ataxia (Taylor, C.P. (213) 151)
Ventricular papillary muscle; Contractile force; K* channel openers;
Sulfonylurea antidiabetics; P, purinoceptor agonists (Bott, A. (213)
Analgesic toierance
141)
Opioid interactions; Morphine; Physical dependence; Nor-bi-
naltorphimine (nor-BNI) (Suzuki, T. (213) 91)
Adenosine
Antianginal vasodilator; Antihypertensive vasodilator; Gliben-
Anaphylaxis
clamide-sensitive K* channels; 2-(1-Octynyl)-adenosine (YT-146)
Haematological alterations; Death; Azelastine (Castro-Faria-Neto,
(Yoneyama, F. (213) 199)
H.C. (213) 183)
Adenylate cyclase
Angiotensin-converting enzyme inhibitors
Dopamine D, receptors; Dopamine D, receptors; Circling be-
Cough reflex; Enalapril; Diuretics; Hydrochlorothiazide (Kamei, J.
haviour; Stereotyped behaviour; Locomotor activity (Arnt, J. (213)
(213) 137)
259)
Anion transport
Adrenergic contraction
Glisoxepide; Glibenclamide; Biliary elimination; Liver; Sulfonylurea;
Urethra (dog); Neurogenic response; Non-adrenergic, non-
K* channel (ATP-dependent) (Petzinger, E. (213) 381)
cholinergic relaxation (Hashimoto, S. (213) 117)
Anococcygeus
Adrenergic neurotransmission Efaroxan; Idazoxan; Prazosin; Vas deferens; Glucose homeostasis:
Heart; U46619; ONO11006; Thromboxane B, (Mantelli, L. (213) 79)
(Pithed rat) (Berridge, T.L. (213) 205)
a,-Adrenoceptors ANP (atrial natriuretic polypeptide)
Rilmenidine; Clonidine; Noradrenaline release; Voltammetry (in Norepinephrine; Neuromodulation; cGMP (Giridhar, J. (213) 317)
vivo); Hypothalamus (Suaud-Chagny, M.F. (213) 305)
Antianginal vasodilator
B-Adrenoceptors (prejunctional) Adenosine; Antihypertensive vasodilator; Glibenclamide-sensitive
CGP 20712A; ICI 118,551; Isoprenaline; Noradrenaline release K* channels; 2-(1-Octynyl)-adenosine (YT-146) (Yoneyama, F. (213)
(Mian, M.A. (213) 47) 199)
Airway hyperreactivity Anticholinergic drugs
Interleukin-1 receptor antagonists; Substance P; Bronchoalveolar Dystonia; Dopamine; Acetylcholine; Haloperidol; Levodopa; Apo-
lavage; Airway leukoctyes (Selig, W. (213) 331) morphine (Loscher, W. (213) 31)
476
Antihypertensive vasodilator Endothelin-l; Cyclosporine; Hypertension; Mesenteric artery
Adenosine; Antianginal vasodilator; Glibenclamide-sensitive K° (Takeda, Y. (213) 445)
channels; 2-(1-Octynyl)-adenosine (YT-146) (Yoneyama, F. (213) 199)
Bradykinin
Antipsychotics Resiniferatoxin; Capsaicin; Tachykinins; Substance P; Iris sphincter
(+)SK&F 10,047; Dopamine release (Volonté, M. (213) 163) muscle (rabbit); Tachyphylaxis (Wang, Z.-Y. (213) 235)
Airway microvascular leakage; Bradykinin receptors; Bronchocon-
Anxiolytic
5-HT receptors; Blood pressure; Dorsal raphe nucleus (Corley, K.C. striction; Hoe 140; PAF (platelet-activating factor, PAF-acether)
(213) 417) (Sakamoto, T. (213) 367)
Bradykinin receptors
Apomorphine
Dystonia; Dopamine; Acetylcholine; Anticholinergic drugs; Airway microvascular leakage; Bradykinin; Bronchoconstriction; Hoe
Haloperidol; Levodopa (Loscher, W. (213) 31) 140; PAF (platelet-activating factor, PAF-acether) (Sakamoto, T.
(213) 367)
Arthus reaction
Immune-complex alveolitis; PAF (platelet-activating factor, PAF- Brain damage
acether); Eicosanoids (Tavares de Lima, W. (213) 63) Tacrine; Seizures; LiCl; Nitric oxide (NO); L-NAME (N“®-nitro-L-
arginine methyl ester) (Bagetta, G. (213) 301)
Ataxia
Bromosulfophthalein
AMPA (2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionate;
Glisoxepide; Glibenclamide; Organic anions; Monocarboxylate trans-
Quinoxalinedione; Epilepsy; Seizure (Taylor, C.P. (213) 151)
port; DIDS (4,4-diisothiocyano-2,2’-stilbenedisulfonate); Bumet-
anide; Oleate (Fuckel, D. (213) 393)
ATP
Suramin; P, purinoceptors; Locus coeruleus neurones; Firing rate
Bronchoalveolar lavage
(Tschopl, M. (213) 71)
Interleukin-| receptor antagonists; Airway hyperreactivity; Substance
P; Airway leukoctyes (Selig, W. (213) 331)
Autonomic ganglia
Sympathetic ganglia (bullfrog); Compound 48/80; Ganglionic trans-
Bronchoconstriction
mission; Neuronal excitability; Spike afterhyperpolarization (Hepp-
Airway microvascular leakage; Bradykinin; Bradykinin receptors; Hoe
ner, T.J. (213) 427)
140; PAF (platelet-activating factor, PAF-acether) (Sakamoto, T.
(213) 367)
Autonomic regulation
Tachykinin; Neuropeptide K; Cardiovascular responses; Cate-
Bumetanide
cholamines (Décarie, A. (213) 125)
Glisoxepide; Glibenclamide; Organic anions; Monocarboxylate trans-
port; Bromosulfophthalein; DIDS (4,4-diisothiocyano-2,2’-stil-
Azelastine
benedisulfonate); Oleate (Fuckel, D. (213) 393)
Anaphylaxis; Haematological alterations; Death (Castro-Faria-Neto,
H.C. (213) 183)
BW 737C
Dopamine D, receptors; Dopamine D, receptors; Dopamine D, /D,
Behaviour
receptor interactions; Behaviour; Jerking; SCH 39166; NO 756; A-
Phorbol 12-myristate,13-acetate; Phorbol 12,13-dibutyrate; Protein
69024 (Daly, S.A. (213) 251)
kinase C; Epilepsy; Staurosporine (Smith, S.E. (213) 133)
Ca**
Dopamine D, receptors; Dopamine D, receptors; Dopamine D, /D,
1,25-Dihydroxyvitamin D, binding; Choroid plexus; 1,25-Dihydroxy-
receptor interactions; Jerking; SCH 39166; NO 756; A-69024; BW
vitamin receptors (Walters, M.R. (213) 309)
737C (Daly, S.A. (213) 251)
Capsaicin
Benzodiazepine receptors
Resiniferatoxin; Bradykinin; Tachykinins; Substance P; Iris sphincter
Flumazenil; PET (positron emission tomography) (Abadie, P. (213)
muscle (rabbit); Tachyphylaxis (Wang, Z.-Y. (213) 235)
107)
Cardioprotection
Bicuculline Pindolol; Ischemia; Reperfusion; Sympathomimetic activity (intrin-
Substance P; GABA (y-aminobutyric acid); Nucleus tractus solitarii; sic); (Rat) (Nasa, Y. (213) 171)
(Evoked responses); (Rat) (Pérez, H. (213) 435)
Cardiovascular responses
Biliary elimination Tachykinin; Neuropeptide K; Catecholamines; Autonomic regulation
Glisoxepide; Glibenclamide; Anion transport; Liver; Sulfonylurea; (Décarie, A. (213) 125)
K* channel (ATP-dependent) (Petzinger, E. (213) 381)
Catecholamines
Blood pressure Tachykinin; Neuropeptide K; Cardiovascular responses; Autonomic
Cocaine; Cocaine methiodide; Heart rate; Norepinephrine; (Squirrel regulation (Décarie, A. (213) 125)
monkey) (Schindler, C.W. (213) 99)
CCK-8 (cholecystokinin-8)
5-HT receptors; Anxiolytic; Dorsal raphe nucleus (Corley, K.C. (213) Insulin secretion; CCK, receptors; CCK, receptors; L-364,718;
417) L-365,260 (Karlsson, S. (213) 145)
CCK, receptors 5-CT (5-carboxyamidotryptamine )
Insulin secretion; CCK-8 (cholecystokinin-8); CCK, receptors; L- 5-HT (5-hydroxytryptamine, serotonin); Sumatriptan; 5-HT,, bind-
364,718; L-365,260 (Karlsson, S. (213) 145) ing site (Beer, M.S. (213) 193)
CCK, receptors Cyclosporine
Insulin secretion; CCK-8 (cholecystokinin-8); CCK, receptors; L- Endothelin-1; Hypertension; Mesenteric artery; Blood pressure
364,718; L-365,260 (Karlsson, S. (213) 145) (Takeda, Y. (213) 445)
Cerebellar diazepam-insensitive binding Cytochrome P-450
Ro 15-4513; Substrate specificity; Alcohol sensitivity; (Selected rat Plasminogen activator (tissue-type); Von Willebrand factor; En-
lines) (Korpi, E.R. (213) 323) dothelial cell secretion; Phospholipase C; Pertussis toxin (Tranquille,
N. (213) 285)
CGP 20712A
ICI 118,551; Isoprenaline; Noradrenaline release; B-Adrenoceptors DAMGO ([D-Ala’,MeP*-hole] e*n,keGphlalyin )
(prejunctional) (Mian, M.A. (213) 47) DPLPE ({D-Pen’,L-Pen® Jenkephalin); SKF 38393; Naltrindole; Lo-
comotor activity; (Mouse) (Toyoshi, T. (213) 25)
CGP37849
NMDA receptors; CGP39551; Dizocilpine; Spatial orientation task; Death
(Rat) (Bischoff, C. (213) 269) Anaphylaxis; Haematological alterations; Azelastine (Castro-Faria-
Neto, H.C. (213) 183)
CGP39551
NMDA receptors; CGP37849; Dizocilpine; Spatial orientation task; Dependence
(Rat) (Bischoff, C. (213) 269) Vigabatrin; Tolerance; GABA (y-aminobutyric acid); Glutamate;
Kindling; Epilepsy (Rundfeldt, C. (213) 351)
CHAPS (3-3 cholamidopropyl dimethylammonium _1-propane
sulphonate) DIDS (4,4-diisothiocyano-2,2'-stilbenedisulfonate)
DL-Propranolol; Nitric oxide (NO); EDRF (endothelium-derived Glisoxepide; Glibenclamide; Organic anions; Monocarboxylate trans-
relaxing factor); N©-Nitro-L-arginine; Hindquarters (rat) (Mota- port; Bromosulfophthalein; Bumetanide; Oleate (Fiickel, D. (213)
Filipe, H. (213) 227) 393)
Choroid plexus 1,25-Dihydroxyvitamin D, binding
1,25-Dihydroxyvitamin D, binding; 1,25-Dihydroxyvitamin receptors; Choroid plexus; 1,25-Dihydroxyvitamin receptors; Ca?* (Walters,
Ca** (Walters, M.R. (213) 309) M.R. (213) 309)
Circling behaviour 1,25-Dihydroxyvitamin receptors
Dopamine D, receptors; Dopamine D, receptors; Adenylate cy- 1,25-Dihydroxyvitamin D, binding; Choroid plexus; Ca** (Walters,
clase; Stereotyped behaviour; Locomotor activity (Arnt, J. (213) 259) M.R. (213) 309)
Clonidine Diuretics
Rilmenidine; Noradrenaline release; Voltammetry (in vivo); a@,>- Cough reflex; Angiotensin-converting enzyme inhibitors; Enalapril;
Adrenoceptors; Hypothalamus (Suaud-Chagny, M.F. (213) 305) Hydrochlorothiazide (Kamei, J. (213) 137)
Cocaine Dizocilpine
Cocaine methiodide; Blood pressure; Heart rate; Norepinephrine; NMDA receptors; CGP37849; CGP39551; Spatial orientation task;
(Squirrel monkey) (Schindler, C.W. (213) 99) (Rat) (Bischoff, C. (213) 269)
Cocaine methiodide DL-Propranolol
Cocaine; Blood pressure; Heart rate; Norepinephrine; (Squirrel Nitric oxide (NO); EDRF (endothelium-derived relaxing factor);
monkey) (Schindler, C.W. (213) 99) N°-Nitro-L-arginine; CHAPS (3-3 cholamidopropyl dimethylammo-
nium 1l-propane sulphonate); Hindquarters (rat) (Mota-Filipe, H.
Compound 48 /80 (213) 227)
Sympathetic ganglia (bullfrog); Autonomic ganglia; Ganglionic trans-
mission; Neuronal excitability; Spike afterhyperpolarization (Hepp- DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane)
ner, T.J. (213) 427) 5-HT, receptors; Glucose; Insulin; Sympathoadrenal system
(Baudrie, V. (213) 41)
Co-neurotransmission
Noradrenaline; Neuropeptide Y (NPY) (Montastruc, P. (213) 159) Dopamine
Dystonia; Acetylcholine; Anticholinergic drugs; Haloperidol; Levo-
Contractile force dopa; Apomorphine (Loscher, W. (213) 31)
Ventricular papillary muscle; Action potentials; K~ channel open-
ers; Sulfonylurea antidiabetics; P, purinoceptor agonists (Bott, A. Dopamine cells
(213) 141) Extracellular recording; Neurokinin receptors (Overton, P. (213) 165)
Cough reflex Dopamine D, /D, receptor interactions
Angiotensin-converting enzyme inhibitors; Enalapril; Diuretics; Hy- Dopamine D, receptors; Dopamine D, receptors; Behaviour; Jerk-
drochlorothiazide (Kamei, J. (213) 137) ing; SCH 39166; NO 756; A-69024; BW 737C (Daly, S.A. (213) 251)
478
Dopamine D, receptors Enalapril
Dopamine D, receptors; Passive avoidance learning; (Mouse) Cough reflex; Angiotensin-converting enzyme inhibitors; Diuretics;
(Ichihara, K. (213) 243) Hydrochlorothiazide (Kamei, J. (213) 137)
Dopamine D, receptors; Dopamine D, /D, receptor interactions; B-Endorphin
Behaviour; Jerking; SCH 39166; NO 756; A-69024; BW 737C (Daly, Heat intensities (different); Tail-flick response; Paw-licking response;
S.A. (213) 251) Morphine (Suh, H.H. (213) 337)
Dopamine D, receptors; Adenylate cyclase; Circling behaviour; Endothelial cell secretion
Stereotyped behaviour; Locomotor activity (Arnt, J. (213) 259) Plasminogen activator (tissue-type); Von Willebrand factor; Phos-
pholipase C; Cytochrome P-450; Pertussis toxin (Tranquille, N. (213)
Dopamine D, receptors 285)
Dopamine D, receptors; Passive avoidance learning; (Mouse)
(Ichihara, K. (213) 243) Endothelin-1
Cyclosporine; Hypertension; Mesenteric artery; Blood pressure
Dopamine D, receptors; Dopamine D, /D, receptor interactions; (Takeda, Y. (213) 445)
Behaviour; Jerking; SCH 39166; NO 756; A-69024; BW 737C (Daly,
S.A. (213) 251) Endothelin peptides
Pulmonary vascular bed; U46619; Thromboxane A, /endoperoxide
Dopamine D, receptors; Adenylate cyclase; Circling behaviour; receptor-mediated responses; Sulotroban; PAF (platelet-activating
Stereotyped behaviour; Locomotor activity (Arnt, J. (213) 259) factor, PAF-acether) (Nossaman, B.D. (213) 1)
Dopamine release Endothelium
Nigrostriatal hemitransection; Dopamine uptake; Acetylcholine re- VIP (vasoactive intestinal polypeptide); Relaxation; Glibenclamide;
lease; Ganglioside administration; (Recovery of function) (Raiteri, Mesenteric artery (rabbit) (Hattori, Y. (213) 147)
M. (213) 17)
Epilepsy
(+ )SK&F 10,047; Antipsychotics (Volonté, M. (213) 163) Phorbol 12-myristate,13-acetate; Phorbol 12,13-dibutyrate; Protein
kinase C; Behaviour; Staurosporine (Smith, S.E. (213) 133)
NMDA receptors; Acetylcholine release; Amantadine; Neostriatum
(Stoof, J.C. (213) 439) AMPA (2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionate;
Quinoxalinedione; Seizure; Ataxia (Taylor, C.P. (213) 151)
Dopamine uptake
Nigrostriatal hemitransection; Dopamine release; Acetylcholine re- Absence seizures; GABA, receptors; GABA, receptors; y-Hy-
lease; Ganglioside administration; (Recovery of function) (Raiteri, droxybutyric acid; Pentylenetetrazole (Snead, III, O.C. (213) 343)
M. (213) 17)
Vigabatrin; Tolerance; Dependence; GABA (y-aminobutyric acid);
Dorsal raphe nucleus Glutamate; Kindling (Rundfeldt, C. (213) 351)
5-HT receptors; Blood pressure; Anxiolytic (Corley, K.C. (213) 417)
Excitotoxicity
DPLPE ([D-Pen’,L-Pen*]enkephalin) Aminooxyacetic acid; Kynurenic acid; Kynurenine; Microdialysis;
DAMGO ([D-Ala’?,MePhe*,Gly°-olJenkephalin); SKF 38393; Nal- Neuroprotection (Wu, H.-Q. (213) 375)
trindole; Locomotor activity; (Mouse) (Toyoshi, T. (213) 25)
Extracellular recording
Dystonia Dopamine cells; Neurokinin receptors (Overton, P. (213) 165)
Dopamine; Acetylcholine; Anticholinergic drugs; Haloperidol; Levo-
dopa; Apomorphine (Léscher, W. (213) 31) Feeding behaviour
Galanin; Sexual behaviour; (Male rat) (Poggioli, R. (213) 87)
EDRF (endothelium-derived relaxing factor)
DL-Propranolol; Nitric oxide (NO); N©-Nitro-L-arginine; CHAPS Fentanyl
(3-3 cholamidopropyl dimethylammonium 1-propane sulphonate); Opiates; Lofentanil; Ileum; Vas deferens; (Receptor binding) (Mag-
Hindquarters (rat) (Mota-Filipe, H. (213) 227) uire, P. (213) 219)
EEG power spectra Firing rate
Morphine; Naltrindole; Tolerance (Stamidis, H. (213) 9) ATP; Suramin; P, purinoceptors; Locus coeruleus neurones (TschopIl,
M. (213) 71)
Efaroxan
Idazoxan; Prazosin; Vas deferens; Anococcygeus; Glucose homeosta- Flumazenil
sis; (Pithed rat) (Berridge, T.L. (213) 205) Benzodiazepine receptors; PET (positron emission tomography)
(Abadie, P. (213) 107)
Glibenclamide; Plasma insulin; Plasma glucose (Berridge, T.L. (213)
213) p-Fluoro-hexahydro-sila-difenidol
Muscarinic receptor subtypes; Muscarinic receptor agonists (M,-
Eicosanoids selective); Muscarinic receptor antagonists (M,-selective); Smooth
Immune-complex alveolitis; Arthus reaction; PAF (platelet-activating muscle (arteriolar); Submucosal plexus (guinea-pig); Stereoselectivity
factor, PAF-acether) (Tavares de Lima, W. (213) 63) (at muscarinic receptors); Videomicroscopy (Bungardt, E. (213) 53)
479
GABA (y-aminobutyric acid) Vigabatrin; Tolerance; Dependence; GABA (y-aminobutyric acid);
Vigabatrin; Tolerance; Dependence; Glutamate; Kindling; Epilepsy Kindling; Epilepsy (Rundfeldt, C. (213) 351)
(Rundfeldt, C. (213) 351)
cGMP
Substance P: Bicuculline; Nucleus tractus solitarii; (Evoked re- ANP (atrial natriuretic polypeptide); Norepinephrine; Neuromodula-
sponses); (Rat) (Pérez, H. (213) 435) tion (Giridhar, J. (213) 317)
GABA, receptors Haematological alterations
Absence seizures; Epilepsy; GABA, receptors; y-Hydroxybutyric Anaphylaxis; Death; Azelastine (Castro-Faria-Neto, H.C. (213) 183)
acid; Pentylenetetrazole (Snead, II], O.C. (213) 343)
Haemodynamics
GABA , receptors L-NMMA (N“-monomethyl-L-arginine; L-NAME (N@-nitro-L-
Absence seizures; Epilepsy; GABA, receptors; y-Hydroxybutyric arginine methyl ester); Hypertension; (Brattleboro rat) (Gardiner,
acid; Pentylenetetrazole (Snead, II], O.C. (213) 343) S.M. (213) 449)
Inaperisone hydrochloride; Micturition reflex; Rhythmic bladder Haloperidol
contraction; (Rat) (Morikawa, K. (213) 409) Dystonia; Dopamine; Acetylcholine; Anticholinergic drugs; Levo-
dopa; Apomorphine (Loscher, W. (213) 31)
Galanin
Heart
Sexual behaviour; Feeding behaviour; (Male rat) (Poggioli, R. (213)
Adrenergic neurotransmission; U46619; ONO11006; Thromboxane
87)
B, (Mantelli, L. (213) 79)
Ganglionic transmission
Heart rate
Svmpathetic ganglia (bullfrog); Autonomic ganglia; Compound
Cocaine; Cocaine methiodide; Blood pressure; Norepinephrine;
48 /80; Neuronal excitability; Spike afterhyperpolarization (Heppner,
(Squirrel monkey) (Schindler, C.W. (213) 99)
T.J. (213) 427)
Heat intensities (different)
Ganglioside administration
Tail-flick response; Paw-licking response; B-Endorphin; Morphine
Nigrostriatal hemitransection; Dopamine uptake; Dopamine release;
(Suh, H.H. (213) 337)
Acetylcholine release; (Recovery of function) (Raiteri, M. (213) 17)
Hindquarters (rat)
Glibenclamide
DL-Propranolol; Nitric oxide (NO); EDRF (endothelium-derived
VIP (vasoactive intestinal polypeptide); Relaxation; Endothelium;
relaxing factor); N©-Nitro-L-arginine; CHAPS (3-3 cholamidopropy!|
Mesenteric artery (rabbit) (Hattori, Y. (213) 147)
dimethylammonium 1|-propane sulphonate) (Mota-Filipe, H. (213)
227)
Efaroxan; Plasma insulin; Plasma glucose (Berridge, T.L. (213) 213)
Histamine
Glisoxepide; Biliary elimination; Anion transport; Liver; Sulfonyl-
Glutamate; NMDA _ receptors; Microdialysis; Hypothalamus
urea; K* channel (ATP-dependent) (Petzinger, E. (213) 381)
(Okakura, K. (213) 189)
Glisoxepide; Organic anions; Monocarboxylate transport; Bromosul-
Hoe 140
fophthalein; DIDS (4,4-diisothiocyano-2,2’-stilbenedisulfonate);
Airway microvascular leakage; Bradykinin; Bradykinin receptors;
Bumetanide; Oleate (Fickel, D. (213) 393)
Bronchoconstriction; PAF (platelet-activating factor, PAF-acether)
(Sakamoto, T. (213) 367)
Glibenclamide-sensitive K * channels
Adenosine; Antianginal vasodilator; Antihypertensive vasodilator;
5-HT,, binding site
2-(1-Octynyl)-adenosine (YT-146) (Yoneyama, F. (213) 199)
5-HT (S5-hydroxytryptamine, serotonin); 5-CT (S-carboxyamido-
tryptamine); Sumatriptan (Beer, M.S. (213) 193)
Glisoxepide
Glibenclamide; Biliary elimination; Anion transport; Liver; Sulfonyl- 5-HT (5-hydroxytryptamine, serotonin)
urea; K* channel (ATP-dependent) (Petzinger, E. (213) 381) 5-CT (5-carboxyamidotryptamine); Sumatriptan; 5-HT,, binding site
(Beer, M.S. (213) 193)
Glibenclamide; Organic anions; Monocarboxylate transport; Bromo-
sulfophthalein; DIDS (4,4-diisothiocyano-2,2'-stilbenedisulfonate) ; 5-HT,-like receptors; Intragastric pressure; 5-HT receptor antago-
Bumetanide; Oleate (Fickel, D. (213) 393) nists; (Rat) (Dhasmana, K.M. (213) 293)
Glucose 5-HT, -like receptors
DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane); 5-HT,_ re- 5-HT (5-hydroxytryptamine, serotonin); Intragastric pressure; 5-HT
ceptors; Insulin; Sympathoadrenal system (Baudrie, V. (213) 41) receptor antagonists; (Rat) (Dhasmana, K.M. (213) 293)
Glucose homeostasis 5-HT rec*™tor antagonists
Efaroxan; Idazoxan; Prazosin; Vas deferens; Anococcygeus; (Pithed 5-HT (5-hydroxytryptamine, serotonin); 5-HT,-like receptors; Intra-
rat) (Berridge, T.L. (213) 205) gastric pressure; (Rat) (Dhasmana, K.M. (213) 293)
Glutamate 5-HT receptors
Histamine; NMDA receptors; Microdialysis; Hypothalamus Blood pressure; Anxiolytic; Dorsal raphe nucleus (Corley, K.C. (213)
(Okakura, K. (213) 189) 417)
480
5-HT, receptors Iris sphincter muscle (rabbit)
DOI (1-(2,5-dimethoxy-4-iodopheny])-2-aminopropane); Glucose; In- Resiniferatoxin; Capsaicin; Bradykinin; Tachykinins; Substance P:
sulin; Sympathoadrenal system (Baudrie, V. (213) 41) Tachyphylaxis (Wang, Z.-Y. (213) 235)
Hydrochlorothiazide Ischemia
Cough reflex; Angiotensin-converting enzyme inhibitors; Enalapril; Pindolol; Reperfusion; Cardioprotection; Sympathomimetic activity
Diuretics (Kamei, J. (213) 137) (intrinsic); (Rat) (Nasa, Y. (213) 171)
y -Hydroxybutyric acid Isoprenaline
Absence seizures; Epilepsy; GABA, receptors; GABA, receptors; CGP 20712A; ICI 118,551; Noradrenaline release; B-Adrenoceptors
Pentylenetetrazole (Snead, III, O.C. (213) 343) (prejunctional) (Mian, M.A. (213) 47)
Hypertension Jerking
Endothelin-1; Cyclosporine; Mesenteric artery; Blood pressure Dopamine D, receptors; Dopamine D, receptors; Dopamine D, /D,
(Takeda, Y. (213) 445) receptor interactions; Behaviour; SCH 39166; NO 756; A-69024; BW
737C (Daly, S.A. (213) 251)
L-NMMA (N®%-monomethyl-L-arginine; L-NAME (N°©-nitro-L-
arginine methyl ester); Haemodynamics; (Brattleboro rat) (Gardiner, K * channel (ATP-dependent)
S.M. (213) 449) Glisoxepide; Glibenclamide; Biliary elimination; Anion transport;
Liver; Sulfonylurea (Petzinger, E. (213) 381)
Hypothalamus
Histamine; Glutamate; NMDA receptors; Microdialysis (Okakura, K * channel openers
K. (213) 189) Ventricular papillary muscle; Contractile force; Action potentials;
Sulfonylurea antidiabetics; P, purinoceptor agonists (Bott, A. (213)
Rilmenidine; Clonidine; Noradrenaline release; Voltammetry (in 141)
vivo); a»-Adrenoceptors (Suaud-Chagny, M.F. (213) 305)
Ketamine
ICI 118,551 NMDA (N-methyl-D-aspartate); lonic channels; (Enantiomer)
CGP 20712A; Isoprenaline; Noradrenaline release; B-Adrenoceptors (Zeilhofer, H.U. (213) 155)
(prejunctional) (Mian, M.A. (213) 47)
Kindling
Idazoxan Vigabatrin; Tolerance; Dependence; GABA (y-aminobutyric acid);
Efaroxan; Prazosin; Vas deferens; Anococcygeus; Glucose homeosta- Glutamate; Epilepsy (Rundfeldt, C. (213) 351)
sis; (Pithed rat) (Berridge, T.L. (213) 205)
Kynurenic acid
lleum Aminooxyacetic acid; Excitotoxicity; Kynurenine; Microdialysis; Neu-
Opiates; Fentanyl; Lofentanil; Vas deferens; (Receptor binding) roprotection (Wu, H.-Q. (213) 375)
(Maguire, P. (213) 219)
Kynurenine
Immune-complex alveolitis Aminooxyacetic acid; Excitotoxicity; Kynurenic acid; Microdialysis;
Arthus reaction; PAF (platelet-activating factor, PAF-acether); Neuroprotection (Wu, H.-Q. (213) 375)
Eicosanoids (Tavares de Lima, W. (213) 63)
L-364,718
Inaperisone hydrochloride Insulin secretion; CCK-8 (cholecystokinin-8); CCK , receptors; CCK ,
Micturition reflex; Rhythmic bladder contraction; GABA, recep- receptors; L-365,260 (Karlsson, S. (213) 145)
tors; (Rat) (Morikawa, K. (213) 409)
L-365,260
Insulin Insulin secretion; CCK-8 (cholecystokinin-8); CCK , receptors; CCK ,
DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane); 5-HT,_ re- receptors; L-364,718 (Karlsson, S. (213) 145)
ceptors; Glucose; Sympathoadrenal system (Baudrie, V. (213) 41)
Levodopa
Insulin secretion Dystonia; Dopamine; Acetylcholine; Anticholinergic drugs;
CCK-8 (cholecystokinin-8); CCK, receptors; CCK, receptors; L- Haloperidol; Apomorphine (Léscher, W. (213) 31)
364,718; L-365,260 (Karlsson, S. (213) 145)
LiCl
Interleukin-1 receptor antagonists Tacrine; Seizures; Brain damage; Nitric oxide (NO); L-NAME (N°®-
Airway hyperreactivity; Substance P; Bronchoalveolar lavage; Airway nitro-L-arginine methyl ester) (Bagetta, G. (213) 301)
leukoctyes (Selig, W. (213) 331)
Liver
Intragastric pressure Glisoxepide; Glibenclamide; Biliary elimination; Anion transport;
5-HT (5-hydroxytryptamine, serotonin); 5-HT,-like receptors; 5-HT Sulfonylurea; K* channel (ATP-dependent) (Petzinger, E. (213) 381)
receptor antagonists; (Rat) (Dhasmana, K.M. (213) 293)
Locomotor activity
Ionic channels DAMGO ({D-Ala*,MePhe*,Gly°-oljenkephalin); DPLPE ({D-
Ketamine; NMDA (N-methyl-D-aspartate); (Enantiomer) (Zeilhofer, Pen*,L-Pen® Jenkephalin); SKF 38393; Naltrindole; (Mouse) (Toyoshi,
H.U. (213) 155) T. (213) 25)